Russell Investments Group
AVIR icon

Russell Investments Group’s Atea Pharmaceuticals AVIR Stock Holding History

Russell Investments Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255K Buy
54,892
+26,882
+96% +$134K ﹤0.01% 3082
2026
Q1 		$148K Buy
28,010
+13,340
+91% +$61.3K ﹤0.01% 2955
2025
Q4 		$52.4K Buy
14,670
+1,459
+11% +$4.64K ﹤0.01% 3286
2025
Q3 		$38.3K Sell
13,211
-20,047
-60% -$68.5K ﹤0.01% 3375
2025
Q2 		$120K Sell
33,258
-21,644
-39% -$64.5K ﹤0.01% 2776
2025
Q1 		$164K Buy
54,902
+54,398
+10,793% +$170K ﹤0.01% 2645
2024
Q4 		$1.69K Sell
504
-598
-54% -$1.99K ﹤0.01% 3469
2024
Q3 		$3.69K Buy
1,102
+598
+119% +$2.17K ﹤0.01% 3279
2024
Q2 		$1.67K Sell
504
-170
-25% -$634 ﹤0.01% 3374
2024
Q1 		$2.72K Sell
674
-4,236
-86% -$16.6K ﹤0.01% 3031
2023
Q4 		$15K Buy
4,910
+241
+5% +$730 ﹤0.01% 2782
2023
Q3 		$14K Buy
4,669
+161
+4% +$548 ﹤0.01% 2939
2023
Q2 		$16.9K Hold
4,508
– – ﹤0.01% 2870
2023
Q1 		$15.1K Sell
4,508
-12,500
-73% -$50.7K ﹤0.01% 2844
2022
Q4 		$81.8K Buy
17,008
+12,500
+277% +$63.2K ﹤0.01% 2695
2022
Q3 		$25K Buy
4,508
+905
+25% +$6.93K ﹤0.01% 2794
2022
Q2 		$26K Sell
3,603
-5,939
-62% -$40.5K ﹤0.01% 2775
2022
Q1 		$67K Sell
9,542
-155,420
-94% -$1.06M ﹤0.01% 2608
2021
Q4 		$1.48M Buy
164,962
+22,448
+16% +$350K ﹤0.01% 1953
2021
Q3 		$4.93M Buy
142,514
+140,818
+8,303% +$3.91M 0.01% 1262
2021
Q2 		$41K Buy
+1,696
New +$51K ﹤0.01% 3147

Other funds holding AVIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's AVIR Position: Q2 2026 in Review

Russell Investments Group increased its Atea Pharmaceuticals (AVIR) stake by 96% in Q2 2026, buying an estimated $134K and bringing the position to 54,892 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #3082.

Russell Investments Group first reported a position in AVIR in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.93M in Q3 2021. 40 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Russell Investments Group held 54,892 shares of Atea Pharmaceuticals worth $255K as of Q2 2026.
  • Russell Investments Group bought 26,882 Atea Pharmaceuticals shares in Q2 2026, an estimated $134K.
  • Atea Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3082 holding.
  • Russell Investments Group first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Russell Investments Group's Atea Pharmaceuticals position peaked at $4.93M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.